The positive impact of essential oils and compounds has been known for a long time. Essential oils are multicomponent mixtures and obtained by steam distillation of leaves or flowers or simply by pressing orange peels for example. Due to the broad-spectrum activity, essential oils can be used for a variety of disorders like sleeping problems, colds or gastrointestinal complaints. The focus of this paper is the use of essential oils against pain in animal studies. The broad use of analgesics like NSAIDs against headaches or menstrual cramps for example, is often associated with unpleasant side effects. Essential oils may help to reduce the analgesic doses.
impulses, which results in a reduction of pain. Nociceptors are nerve endings which respond to noxious cold and heat, high threshold mechanical stimuli and a variety of chemical mediators [6] . To demonstrate antinociceptive properties of EOs, animal experiments were performed. The pain was triggered experimentally.
The following methods can be used:
• In the writhing test an irritant "including phenylbenzoquinone, acetylcholine, dilute hydrochloric or acetic acid, or bradykinin" is intraperitoneally injected. This results in an irritation of "serous membranes of the peritoneal cavity and evoke abdominal contractions, body movements, asymmetric contraction of dorsal abdominal muscles, and reduced locomotion". The assay represents a model for visceral pain but also activates somatic afferents [7] . The acetic acid -induced writhing method is a test model for evaluation of peripheral antinociceptive activity. [8] It was published that acetic acid acts indirectly by inducing the release of PGE 2 , PGF 2α and lipoxygenase products [9] .
the Balkan. Main compounds of L. ochridanum essential oil are α-pinene (33.2 %), α-bisabolol (10.3 %) and chamazulene (14.9 %). L. zernyi EO consists of α-pinene (33.2 %) and α-bisabolol (30.9 %). Oral pre-treatment with both EOs showed a significant dose dependent antinociceptive effect in rats with localised inflammation induced by carrageenan. Doses of at least 45.9 ± 4.9 mg/kg for L. zernyi and 42.4 ± 2.1 mg/kg for L. ochridanum oil were necessary to achieve the desired effect. An anti-oedematous effect could also be observed [10] .
The antinociceptive and antiinflammatory properties of the EO of Eugenia candolleana DC (Myrtaceae) in mice were the focus of a research by Guimarães et al. [11] . The researchers showed that intraperitoneal injection of 25, 50 and 100 mg/kg was able to reduce significantly the number of writhes in the writhing test and the number of paw licks in formalin test during phase 2. The carrageenan-induced leukocyte migration was also inhibited. The reaction time in hot plate test did not change. On the basis of their observations, they concluded that the antinociceptive and antiinflammatory effects of E. candolleana DC EO are probably linked to an inhibition of prostaglandin synthesis or further peripheral pathways [11] .
Hasanein et al. [12] tested whether the EO of Melissa officinalis L.
(Lamiaceae) possesses antinociceptive properties in diabetic rats undergoing formalin test. Non diabetic rats were used as control. They found out that dose of 0.04 mg per day led to significant antinociceptive effects on diabetic hyperalgesia. This effect was less pronounced in control rats using doses of 0.02 and 0.04 mg per day. 0.01 mg per day seemed to be too low to exert any effect [12] . Further research is necessary to investigate the described positive effect on the painful diabetic neuropathy.
Recently, Maham et al. [13] performed various experimental models on mice and rats to assess antinociception triggered by the EO of Artemisia dracunculus L. (Asteraceae) [13] . They also identified the LD 50 dose of the EO as 1250 mg/kg. This suggests that it has a good safety profile. The licking time induced by subplantar injection of 2.5 % formalin was significantly reduced by tarragon EO in doses of 100 and 300 mg/kg in both early (0-5 min post injection) and late (between 15 and 30 minutes post injection) phases. Doses of 30 mg / kg only affected the late phase. In the hotplate test doses of 10-300 mg/kg led to an increase in latency time which confirmed the central involvement in the analgesic profile. Also nociception triggered by acetic acid was significantly inhibited. The opioid antagonist naloxone did not antagonize the analgesic effect in the acetic acid-induced writhing test.
Thus they concluded that "mechanisms other than opioid receptors are involved in the analgesic effect". Morphine was used as standard substance. Acetic acid induced an increase of PGE 2 , PGF 2α , serotonin and histamine in peritoneal fluids. The main compounds of the EO of A. dracunculus are menthol, anethole, anisole, anisic acid, (+)-sabinene, estragole, limonene, pulegone, myrcene, ocimene and β-pinene [13] .
The monoterpenes 1,8-cineole and β-pinene, both found in the EO of Eucalyptus camaldulensis Dehnh. (Myrtaceae) leaves, were evaluated for their antinociceptive properties in a study by Lipai et al. [14] . Tail-flick and hot-plate method in mice and rats were used to reflect the spinal and supraspinal levels. 1,8-Cineole exerted an antinociceptive effect similar to that of opioid-agonist morphine in both models of pain. There appeared to be a significant synergistic effect between morphine and 1,8-cineole, but naloxone was only able to antagonise morphine. β-Pinene showed only supraspinal antinociceptive effects in rats and was able to reverse the antinociceptive effect of morphine, probably by acting as a partial agonist at µ-opioid receptors. This effect was comparable to that of naloxone. The working group also discovered a structure-activityrelation between the two pairs morphine + 1,8-cineole and naloxone + β-pinene. Similarities in the stereochemistry and atomic charges have been shown [14] .
Nogueira et al. [15] observed the antinociceptive effect of the EO of Croton cordiifolius Baill. leaves (Euphorbiaceae) with its major components 1,8-cineole and α-phellandrene in mice. They came to the conclusion that the EO is able to exert an antinociceptive effect in a chemical model of pain, at least in part, by inhibiting the glutamatergic system. Opioid antagonist naloxone did not affect the outcome, which indicates that the opioid system is not involved [15] .
Martínez et al. [16] found out that both the endogenous opioidergic and the serotonergic system via 5-HT 1A receptors participate in the antinociceptive effect of Rosmarinus officinalis L. (Lamiaceae) EO. Intraperitoneal treatment with this EO produced a significant reduction in dysfunction in the PIFIR model (pain-induced functional impairment model in the rat) in a dose-dependent manner, especially at higher doses [16] .
In a recent study Raskovic et al. [17] also dealt with the analgesic properties of orally administered EO of R. officinalis and its pharmacodynamic interactions with acetaminophen and codeine in mice by performing the hot plate test. 1,8-Cineole, camphor and α-pinene were identified as the main constituents. This EO significantly increased the latency time to heat-induced pain between minute 20 and 50 compared to saline-treated group. Doses of 20 mg/kg seemed to be more efficient than doses of 10 mg/kg. The analgesic effect of the EO was slightly higher than that of acetaminophen, but significantly weaker than that of codeine, especially when considering minute 5 to 20 (Table 1) . These findings also support a combination of the EO of rosemary with codeine and acetaminophen in the management of pain. The authors came to the conclusion that this EO shows central analgesic properties and is useful for the management of pain [17] . De Sousa et al. [18] found out that the naturally occurring monoterpene (R)-(+)-pulegone significantly inhibits the nociception induced by formalin and hot plate test. Furthermore, the authors suggested that (R)-(+)-pulegone exerts a central depressant effect due to a "decrease in ambulation and an increase in pentobarbitalinduced sleeping time in mice" [18] . The same working group also determined the relationship between antinociceptive activity and chemical structure of the monoterpene rotundifolone, which occurs in the EO of Mentha × villosa Hudson (Lamiaceae), to find out which functional groups are involved. In the acetic acid-induced pain models in mice, all tested monoterpenes showed a greater antinociceptive effect than rotundifolone itself. Morphine was used as positive control substance. They compared rotundifolone with limonene oxide and found out that the absence of the ketone group did not decrease antinociception. Pulegone oxide and carvone
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Natural Product Communications Vol. 12 (7) 2017 1139 epoxide showed greater antinociception thus they suggested that the position of the functional group influences the action. Treatment with (-)-carvone and (+)-carvone had the greatest influence ( Figure  1 ). The results indicate that specific structural modifications affect the analgesic properties [19] .
Peppermint EO also contains pulegone, but the European Pharmacopoeia stipulates a maximum concentration of 4 % [5] . Invitro studies, performed by Kawata et al. [20] assessed the cyclooxygenase inhibiting effect of monoterpenoids with a pmenthan skeleton. Pulegone, γ-terpinene, α-terpineol and α-carveol acted as a selective cyclooxygenase 2 inhibitor. α-Terpineol showed higher COX-2 inhibition than acetylsalicylic acid.
The aim of the study by da Rocha et al. [21] was to examine the antinociceptive and antiinflammatory properties of α,β-epoxycarvone in mice. Intraperitoneal administration of the monoterpene at doses of 100, 200 or 300 mg/kg showed a significant antinociception in acid-induced abdominal writhing test. Also the formalin induced nociception decreased in the first (300 mg/kg) and second phase (200 and 300 mg /kg). In the hot plate test they registered an increase of latency time at 30 min (at 100, 200 and 300 mg/kg) and at 60 and 120 min (300 mg/kg) after administration. This effect was reversed by naloxone, so the authors concluded that the pronounced antinociceptive effect of α,β-epoxy-carvone was associated with an activation of the opioidergic system [21] .
Oliveira et al. [22] tested whether the synthetic intermediate hydroxydihydrocarvone, which was obtained from (R)-(-)-carvone hydration, has a central antinociceptive effect in intraperitoneal administration. In addition, the authors performed the tail immersion test. Mice which received hydroxydihydrocarvone showed longer response times to the thermal noxious stimulus. Similar results were achieved, but the effect on the formalin and hot plate tests was not blocked by opioid antagonists [22] . Another popular EO is extracted from Thymus vulgaris L. (Lamiaceae). Its main components are thymol and p-cymene. The EO is used as a liniment due to the irritating and stimulating properties [5] .
Mikaili et al. [23] revealed that intra-peritoneal injection of 0.1 mg/ml EO of T. vulgaris led to a significant antinociceptive effect in tail flick test in mice, especially during the first 30 minutes after intervention. After 60 and 90 minutes the observed action wore off. The authors also made the same experiment with the EO of Foeniculum vulgare Mill. (Apiaceae), but there were no significant differences to the control group. Further studies with higher doses of fennel oil are necessary [23] .
Zhang et al. [24] tested the effect of the aroma oils of white pepper (Piper nigrum L. (Piperaceae)), long pepper (Piper longum L.), cinnamon (Cinnamomum cassia Presl. (Lauraceae)), saffron (Crocus sativus L. (Iridaceae)) and myrrh (Commiphora myrrha Engl. (Myrtaceae)) obtained by supercritical fluid CO 2 extraction on nociception and inflammation in mice. As described in previous studies, the antinociceptive effect was measured using the acetic acid-induced writhes and hot plate test method. Oral pre-treatment with an aroma oil blend significantly reduced the number of writhes triggered by intraperitoneal injection of acetic acid solution in a dose-dependent manner. Treatment with 500 or 1000 mg/kg led to fewer writhes compared to the reference indomethacin, but no significant analgesia on the hot plate pain threshold could be measured. The following major constituents have been analysed by GC/MS: β-selinene, aromadendrene, β-elemene, cis piperitol, cis-β-guaiene, 3-heptadecene, δ-cadinene, and β-cadinene. The authors deduced that the aroma oil recipe used in their study may be helpful in stroke treatment [24] . The sesquiterpene β-elemene, for example, is able to pass through the blood-brain barrier and may help to resist inflammation caused by stroke [25] .
Jeena et al. [26] dealt with the EO isolated from the fruits of P. nigrum L. and its pharmacological activities. The authors identified β-caryophyllene (23.9 %) and limonene (14.4 %) as the main constituents. To analyse the antinociceptive activity, 30 mice were divided into five groups. Group 1 acted as the control group, group 2 was treated with acetylsalicylic acid as positive control, and group 3, 4 and 5 received 100, 500 and 1000 mg/kg black pepper EO intraperitoneally 30 minutes before acetic acid administration. The results revealed a reduced number of writhes (Table 2) . Aspirin clearly reduced the number of writhes, followed by 500 mg/kg and 1000 mg/kg black pepper EO. The antinociceptive effect of aspirin (73.9 % inhibition) was superior to the essential oil, but especially at doses of 500 and 100 mg/kg, black pepper also showed a significant antinociception compared to the control group [26] . 2 -receptor. In the study, acute pain was triggered using the hot plate test for thermal nociception and the formalin test for inflammatory pain. Depending on the dosage, β-caryophyllene increased the latency to lick or jump from hot plate and attenuates pain in formalin tests compared to the control group. Neuropathic pain induced by chronic sciatic nerve injury was relieved and a decrease in IL-1β levels was measured. To analyse the mechanism of action, mice were pre-treated with naloxone before β-caryophyllene treatment. It was established that both, the opioid and endo-cannabinoid system are involved in the observed effects, but further studies are required. It seems that only higher doses of 5 or 10 mg/kg of β-caryophyllene cause therapeutic effects [30] .
Barocelli et al. [31] described the antinociceptive effect of orally administrated and inhaled EO of Lavandula hybrida (Lamiaceae) in rodents. The animals received either 100 mg/kg orally, or inhaled 60 minutes. Pain was triggered by acetic acid injection or hot plate. Pre-treatment with the opioid antagonist naloxone, the muscarinic antagonist atropine and the nicotinic antagonist mecamylamin was provided in different sets of mice. Results showed that pretreatment with naloxone prevented the antinociceptive effect in contrast to atropine and mecamylamine in the acetic acid group. In the hot plate test group, the analgesic activity after inhalation was inhibited by naloxone, atropine and mecamylamine pre-treatment. The conclusion can be drawn that opioidergic as well as cholinergic pathways are involved [31] . The monoterpene (-)-linalool is an important constituent of L. hybrida EO and can also be found in the EOs of several other aromatic plants. For example, in Zhumeria majdae Rech.f.& Wendelbo (Lamiaceae) EO in the proportion of 63.4 %. Miraghazadeh et al. [32] examined this particular EO and detected a significant decrease in the number of acetic acidinduced writhes compared to placebo in mice. They also noticed central analgesic properties by performing the hot plate test as well as an antiinflammatory potential in carrageenan induced paw oedema tests in rats. The effects were similar to those of diclofenac sodium, which acted as standard drug [32] .
Peana et al. [33] performed several studies to characterise the mechanisms which are involved in antinociceptive actions of (-)-linalool: In 2003 the authors analysed the antinociceptive potential of linalool and came to the conclusion that (-)-linalool significantly reduces the acid-induced writhing in mice at doses ranging from 25 to 75 mg/kg. They found out that both naloxone and atropine reversed this effect, suggesting that cholinergic and opioidergic systems are involved. For the hotplate test, a model for supraspinal analgesia, higher doses of about 100 mg/kg linalool were necessary. A more pronounced effect of (-)-linalool on the writhing test with its antiinflammatory activity was discerned and a possible confounding influence of the sedative effect of this alcohol because of a dose-dependent increase of locomotor activity [33] .
One year later, a study was published which examined the possible influence of muscarinic M 1 receptor antagonist pirenzepine, naloxone, atropine, the dopamine D 2 receptor antagonist sulpiride, the dopamine D1 receptor antagonist (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and the ATP-sensitive K + channel inhibitor glibenclamide on the antinociceptive effect of (-)-linalool in mice. (-)-Linalool at doses of 50 and 100 mg/kg led to a significant reduction in the acute early phase, but not in the late phase of the formalin model. Higher doses of 150 mg/kg influenced both phases. 100 mg/kg and 150 mg/kg also increased the reaction time in the hot plate test. Oral pretreatment with atropine, naloxone, sulpirid and glibenclamide attenuated the described antinociceptive effects. Pirenzepine and the D 2 receptor antagonist did not show these effects. The scientists concluded that the opening of K + channels may be a consequence of the M 2 , opioid and D 2 receptor stimulation. These receptors are linked to G i /G 0 proteins [34] .
In 2005, the same working group [35] also investigated the effect of this monoterpene alcohol on LPS induced response in a macrophage cell line. The outcome was that the reduction of NO production furnished antinociceptive effects due to an inhibition of nitrite accumulation without inhibiting the LPS-stimulated (lipopolysaccharide) iNOS expression. However, the in-vitro study also showed a failure of this effect if (-)-linalool would not have been applied at the highest concentration regarding both the inhibition of PGE 2 release and COX 2 activity [35] .
Further, Peana et al. [36] published that adenosine A 1 and A 2A receptors are involved in the antinociceptive effect. For testing the effect on mice, the authors used the hot plate test. Besides the important role which adenosine plays as a part of the energy rich molecules ATP and ADP it acts as an endogenous neurotransmitter and modulator via the G protein-coupled family of receptors. [6] It can be concluded that the antinociceptive effects of (-)-linalool occurred at lower doses, at which no side effects regarding the animals gross behaviour were observed [36] .
Glutamate receptors which are divided into two groups -ionotropic and metabotropic -have a decisive influence in nociceptive processes on spinal and peripheral levels. Ionotropic receptors include: NMDA (N-methyl-D-aspartate), AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate) or kainite receptors [6] . In 2008, Batista et al. [37] revealed that (-)-linalool was able to modulate ionotropic glutamate receptors. A solution of 20 μg of Lglutamic acid hydrochloride, substance P, kainic acid, tACPD (trans-aminocyclopentane-1,3-dicarboxylic acid), AMPA or NMDA were injected intraplantarly to the right hind paw. The duration rodents licking the injected paw was measured and considered to correspond with nociception. Before this injection, mice were pretreated with (-)-linalool injection, control animals only received vehicle substance instead. Both systemic and central administration of this monoterpene alcohol led to significant and dose-dependent inhibition of glutamate-induced nociception. Also the biting response induced by glutamate, NMDA, AMPA, substance P and kainate were alleviated. This did not apply for metabotropic glutamatergic receptor agonist trans-ACPD [37] .
Another very interesting animal study by Ghelardini et al. [38] compared the EO of Lavandula angustifolia MILL. (Lamiaceae) with the two sorts of citrus EOs-Citrus reticulata Blanco and C. limon (Rutaceae) -in local anaesthetic activity. Only the EO of lavender was able to reduce drastically the electrically evoked contractions of phrenic-hemidiaphragm in rats as well as to increase the number of stimuli necessary to provoke conjunctival reflexes in rabbits -both in a dose-dependent manner [38] .
A recently published study by Khodabakhsh et al. [39] explored the analgesic and antiinflammatory properties of EO of C. aurantium L. blossoms, also known as neroli, in mice. Furthermore, they investigated whether nitric oxide / cyclic-guanosine monophosphate pathways are involved in those effects. Neroli oil significantly reduced the number of acetic acid -induced writhes compared to Essential oils and compounds against pains Natural Product Communications Vol. 12 (7) 2017 1141 placebo. In the hot plate test, it also increased the latency time significantly. This effect indicates that neroli oil possesses both central and peripheral antinociceptive properties. Diclofenac sodium, which is a NSAID drug (non-steroidal anti-inflammatory drug) with peripheral analgesic effects, acted as positive control. To observe whether the NO/cGMP pathway plays a role in the analgesic activity of neroli oil, mice were pre-treated with L-nitro arginine methyl ester (L-NAME) 0.9 % in a saline solution, a competitive and reversible inhibitor of NO synthase. Neroli oil or sweet almond oil was given 15 minutes after L-NAME as control. Subsequently the hot plate and the acetic acid -induced writhing test were performed. Pre-treatment with L-NAME led to an improvement of the analgesic effect of neroli oil both by producing a change in the number of abdominal constrictions in acetic acidwrithing and hot plate tests. It was also possible to demonstrate the antiinflammatory activity. This effect was similar to those of diclofenac-sodium, especially at doses of 40 mg / kg. Inflammation was triggered by injection of 2 % carrageenan into a hind paw of the rat. The main compounds of the tested EO were linalool (28.5 %), linalyl acetate (19.6 %), nerolidol (9.1 %), (E,E)-farnesol (9.1 %), α-terpineol (4.9 %) and limonene (4.6 %) [39] . The US Food and Drug Administration (FDA) approved neroli oil as generally regarded as safe (GRAS) for internal consumption [40] .
The involvement of the NO/cGMP pathway also was the focus of a research in animals by Guilhon et al. [41] . The authors investigated antiinflammatory and antinociceptive effects of Lippia gracilis Schauer (Verbenaceae) EO and found out that L-NAME reversed the analgesic activity of the EO. Atropine led to the same effect. In addition, it was figured out that the administration of naloxone exerted no influence on the antinociceptive effect. The methods used to induce the pain were acetic acid -induced contortion, formalin-induced licking and hot plate test [41] . Mendes et al. [42] also carried out a study to examine the EO of L. gracilis and its analgesic and antiinflammatory effects. Oral administration at doses of 50, 100 and 200 mg/kg significantly reduced the number of abdominal writhes induced by acetic acid compared to control group [42] . In both studies mentioned above, L. gracilis EO also showed antiinflammatory activity.
The EO from Zingiber officinale Roscoe (Zingiberaceae) was the focus of a research by Jeena et al. [43] . α-Zingiberene (31 %) was identified as the main constituent. 15.4 % ar-curcumene and 14.0 % α-sesquiphellandrene were contained as well. The EO showed a significant reduction in acetic acid-induced writhing movements. Additionally, antiinflammatory and antioxidant properties were discovered [43] . Sulaiman et al. [44] also performed chemical and thermal animal models of nociception to evaluate the potential of the EO of Zingiber zerumbet L. (Rosc.) (Zingiberceae). Intraperitoneal administration of 30, 100 or 300 mg/kg EO led to a significant dose-dependent inhibition of abdominal writhings, comparable to acetylsalicylic acid. It also had a positive effect on the latency time during the hot plate test as well as the formalininduced paw licking test. The main compounds were zerumbone and camphene. Furthermore, an involvement of the opioid system in the analgesic effect of the EO by administration of naloxone was noticed [44] .
Khalid et al. [45] also tested the EO of Z. zerumbet and found out that its antinociceptive properties are probably based on an inhibition of the glutamatergic system and TRPV 1 receptors (transient receptor potential channel [vanilloid] ), as well as an activation of the "L-arginine/nitric oxide/cGMP/protein kinase C/ATP-sensitive K + channel pathway" [45] .
De Araùjo et al. [46] observed the effect of orally administered Alpinia zerumbet (Pers.) Burtt. et Smith (Zingiberaceae) EO in mice. In the acetic acid-induced writhing test, the EO was effective at doses of 30, 100 and 300 mg/kg. In the hot plate test, the latency time was increased only at doses of 100 and 300 mg/kg. In the formalin test, the paw licking time was reduced at 100 mg/kg in the second phase, but inconsistently the time was longer at 300 mg/kg at both phases. At 30 mg/kg, no difference compared to the control group could be detected. The results suggested that the explored EO possesses a dose-dependent antinociceptive effect. It was also found that opioid receptors may be involved [46] .
In folk medicine, the EO of Laurus nobilis L. (Lauraceae) is externally used in treatment of rheumatic pain and hyperaemia. Key ingredients of the leaf EO of L. nobilis include 1,8-cineole, α-and β-pinene, citral and terpineol [47] . α-Pinene, β-pinene and (+)-sabinene have already been known for their antiinflammatory activity. This knowledge is based on experimental models [48, 49] .
A study by Sayyah et al. [50] explored the possible analgesic and antiinflammatory effect of the leaf EO of L. nobilis in tail-flick and formalin tests in mice and rats compared to piroxicam and morphine. The EO inhibited the progressive increase in paw oedema triggered by formalin, similarly to piroxicam in a dosedependent manner. The antiinflammatory effect of this EO occurred later compared to synthetic piroxicam. Antinociception triggered by the EO at the dose of 0.06 ml/kg was similar in potency and early onset of action like morphine and not reversible by naloxone; hence it was concluded that the endogenous opioid system is not involved in the analgesic activity of this EO. A high dose of the EO led to a strong sedation. Further investigation is necessary to definitely identify active compounds as well as the exact mechanism of action [50] .
Hart et al. found out that tea tree oil (TTO) of Melaleuca alternifolia Cheel. (Myrtaceae) which contains 4-terpineol as maincomponent, suppresses the production of inflammatory mediators by activated human monocytes [51] . In the study of Rabelo et al. [52] , the EO of Remirea maritima Aubl. (Cyperaceae) from roots and rhizomes showed central and peripheral analgesic effects after oral administration. The authors used the acetic acid writhing reflex, formalin-induced nociception and carrageenan-induced oedema test in mice. Identified compounds were 43.2 % remirol, 13.8 % cyperene, 5.8 % iso-evodionol, 5.7 % cyperotundone, 4.9 % caryophyllene oxide and 4.6 % rotundene [52] .
A recent study published in 2015 by Khalilzadeh et al. [53] investigated the antinociceptive activity of Vitex agnus-castus L.
(Verbenaceae) EO. α-Pinene (14.8 %), limonene (10.3 %), β-caryophyllene (6.9 %), sabinene (5.3 %), and β-farnesene (5.9 %) were identified as the major components. The EO exerted a pain reduction in both tail immersion and formalin test in male rats. This effect was reversed by naloxone and atropine which suggests that both opioidergic and cholinergic systems were involved. In acetic acid-induced writhing response test the EO also showed analgesic effects [53] .
Concluding remarks
Literature refers to a number of studies dealing with EOs against pain. For example, women during pregnancy and child birth are benefiting from the analgesic properties and low side effects because the therapeutic options are limited. Considering that patients suffering from headaches are frequently struggling with medication induced headache, which is a consequence of the 1142 Natural Product Communications Vol. 12 (7) 2017 Schabauer et al.
overuse of medication, EOs, especially peppermint EO, represent a great alternative to them.
As many studies used animal experiments the results probably cannot be applied to human. Furthermore, one has to argue that animal tests are ethically contentious. However, animal experiments are well suited to assess exact mechanisms of action including the involved receptors. It could be shown that the opioidergic, glutamatergic, serotoninergic and cholinergic systems are involved frequently. Further studies should particularly focus on the application in humans. But the already executed trials and studies however, showed a significant potential for the application of EOs against pain.
To sum up, EOs and their compounds are well suited for the application against pain. They provide a good treatment option, both complementary to conventional methods and as sole therapy against mild complaints. Furthermore, the use of EOs is accompanied with few side effects and well-tolerated by patients
